HEATHER SULLIVAN: Open Payments
NPI 1144692823 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,655 in 209 payments from 23 companies in 2025. Trend: 2023 $6,377 · 2024 $5,634 · 2025 $4,655
Food & beverage: $4,555Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 40 | $756 |
| UCB, Inc. | 26 | $655 |
| ABBVIE INC. | 23 | $444 |
| AstraZeneca Pharmaceuticals LP | 10 | $357 |
| Lilly USA, LLC | 16 | $329 |
| GlaxoSmithKline, LLC. | 18 | $289 |
| Novartis Pharmaceuticals Corporation | 14 | $286 |
| Janssen Biotech, Inc. | 8 | $272 |
| E.R. Squibb & Sons, L.L.C. | 13 | $195 |
| Radius Health, Inc. | 8 | $160 |
Products named: Bimzelx, SAPHNELO, TREMFYA, KRYSTEXXA, BENLYSTA, COSENTYX, TAVNEOS, SKYRIZI.
Industry payments across TX — which companies pay providers there.
